Low dose of COTI-2 can significantly inhibit the proliferation of lung cancer cell line SHP-77, mainly inducing apoptosis and necrosis of most cells by reducing the levels of p-AKT (21). This evidence concerns the gene AKT1 and lung carcinoma.